Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Apr 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 103838901000001114 | MagnaPhos | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 103839001000001116 | MagnaPhos (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| MagnaPhos | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) | Is a | True | MagnaPhos | Inferred relationship | Existential restriction modifier | |
| MagnaPhos 48.6mg (2mmol) capsules (TriOn Pharma Ltd) | Is a | True | MagnaPhos | Inferred relationship | Existential restriction modifier | |
| MagnaPhos 97.2mg (4mmol) capsules (TriOn Pharma Ltd) | Is a | True | MagnaPhos | Inferred relationship | Existential restriction modifier | |
| MagnaPhos 97.2mg (4mmol) chewable tablets (TriOn Pharma Ltd) | Is a | True | MagnaPhos | Inferred relationship | Existential restriction modifier | |
| MagnaPhos 121.25mg/5ml (5mmol/5ml) oral solution (TriOn Pharma Ltd) | Is a | True | MagnaPhos | Inferred relationship | Existential restriction modifier | |
| MagnaPhos 97.2mg/5ml (4mmol/5ml) oral solution (TriOn Pharma Ltd) | Is a | True | MagnaPhos | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR